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license (http://creativecommons.org/Summary Background/Objective: Osteochondral autografting and allografting of the
femoral head have been described as treatments for avascular necrosis without segmental
collapse, fracture, osteochondritis dissecans, and tumours. One long-term study reported that
80% of nonsteroid-treated patients had successful outcomes. Most data are compiled from
small case reports or series. Although these results are encouraging, to the authors’ knowl-
edge, there is no basic scientific evidence regarding optimal graft source or technique reported
in the peer-reviewed literature. The objective of this study was to create a translational
canine model to compare femoral-head osteochondral autografts and allografts with respect
to safety and efficacy.
Methods: With Institutional Animal Care and Use Committee approval, skeletally mature
hound-mix dogs (n Z 6) weighing >20 kg underwent aseptic surgical implantation of osteo-
chondral grafts using a craniolateral approach to the hip, without dislocation. Three graft op-
tions were evaluated: small auto (nZ 3), 6-mm-diameter autograft from the trochlear ridge of
the ipsilateral knee; small allo (nZ 3), 6-mm-diameter fresh (21-day storage) allograft from a
size-matched canine femoral head; or large allo (n Z 3), 14-mm-diameter fresh (21-day stor-
age) allograft from a size-matched canine femoral head. Small grafts were implanted into the
same femoral head of three dogs, and large grafts were implanted alone in the other three
dogs. The dogs were allowed unrestricted activity in their runs, and were walked on a leash
for 15 minutes 5 times/wk. The outcome measures included functional, radiographic, and
arthroscopic assessments at 8 weeks, and functional, chondrocyte viability, and histologic as-
sessments at 6 months after surgery. The pre- and postoperative data were compared fort of Orthopaedic Surgery, University of Missouri School of Medicine, One Hospital Drive, N119,
souri.edu (B.D. Crist).
.10.001
hors. Published by Elsevier (Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND
licenses/by-nc-nd/4.0/).
Femoral-head OCA transplant preclinical model 49statistically significant (p < 0.05) differences. Based on data from the canine study, four hu-
man patients underwent fresh (<28-day storage) osteochondral allografting using large
(>30-mm diameter) size-matched femoral-head grafts. The radiographic, quality of life, and
functional assessments were captured postoperatively.
Results: All grafts had >80% chondrocyte viability at the time of implantation. All grafts
showed radiographic evidence for integration into host bone. Small auto and small allo showed
significant (p < 0.05) loss in range of motion, chondrocyte viability, and articular-cartilage
integrity 8 weeks after implantation, whereas large allo maintained viability and structural
integrity throughout the study period. The large-allo dogs maintained full hip range of motion
and hindlimb function. A similar type of large allograft (>30 mm) was performed in the four
human patients. Due to the defect size, three out of the four human patients required two
large allografts at the time of implantation. At the time of this manuscript’s acceptance,
patient follow-up ranged from 4 months to 18 months. All human patients were full weight-
bearing without an assistive device, and showed no evidence of graft failure or progressive
arthrosis.
Conclusion: These data provide initial translational and clinical evidence for large osteochon-
dral allografts as a potential option for functional resurfacing of full-thickness cartilage de-
fects of the femoral head.
Copyright ª 2015, The Authors. Published by Elsevier (Singapore) Pte Ltd. This is an open ac-
cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Femoral-head defects resulting from trauma or disease
processes pose significant management challenges, espe-
cially when they are large and/or occur in young patients
where total joint arthroplasty is not ideal and other
treatment options are limited. Osteochondral allograft
(OCA) transplantation has been extensively used and
studied for the treatment of large articular defects of the
human knee with good to excellent long-term results re-
ported [1e3]. OCA transplantation for the treatment of
femoral-head defects in human patients has also been
described, but only in the form of case reports or small
case series [4e7]. The largest case series in the peer-
reviewed literature is from 1985, and reported that OCA
transplantation of the femoral head for the treatment of
post-traumatic femoral-head defects, avascular necrosis
without segmental collapse, osteochondritis dissecans,
and tumours to be associated with an 80% long-term suc-
cess rate in patients who did not have a steroid-related
aetiology [7]. However, numerous questions remain
regarding optimal graft size and source and implantation
technique.
The chondrocyte viability in OCAs at the time of
transplantation has been reported to be critically impor-
tant to the clinical success of the surgery [1,8e11]. As
such, different storage methods and implantation tech-
niques have been investigated to try to maintain chon-
drocyte viability in implanted OCAs above minimal
acceptable levels (typically considered to be 70% viable
cells) [8,12e16]. To address these factors, the Missouri
Osteochondral Allograft Preservation System, a serum-free
tissue-preservation method (Cook JL, Hung CT, Lima E,
Stoker A, inventors. Tissue preservation system. United
States patent application #US 2012/0177615 A1. 2012 Jul
12; claims pending 2015 Jun.) that has prolonged the timefor maintenance of acceptable levels of chondrocyte
viability in osteochondral tissues to more than twice as
long the current standard-of-care based on in vitro and
in vivo assessments [8,14,15], and an instrumentation
system for creating tapered grafts that can be implanted
such that chondrocyte viability is better preserved
compared to standard cylindrical grafts [17], were
developed.
Dogs were selected for this large animal model based on
their extensive use in cartilage-repair research, the similar
anatomy, pathologic conditions, treatment options in dogs’
hips in comparison to humans, and successful use of OCAs in
dogs [8,18e20]. In addition, dogs are one of the large ani-
mal species designated by the Food and Drug Administra-
tion and American Society for Testing and Materials
guidelines as acceptable for preclinical studies designed to
test the safety and efficacy of cartilage-repair techniques
for clinical use [21,22].
The purpose of this study was to use a preclinical canine
model to determine the effects of graft size and source and
implantation technique on outcomes for femoral-head
osteochondral transplantation with respect to safety and
efficacy for clinical application in human patients.
Materials and methods
All procedures were approved by the University of Missou-
ri’s Animal Care and Use Committee. Six skeletally mature
(age range 2e4 years) hound-mix (mean body
weight Z 28.2 kg; range 26.7e31.4 kg) purpose-bred
research dogs (Marshall Farms BioResources, North Rose,
NY, USA; US Department of Agriculture #21-A-008) were
used. Complete orthopaedic examination and radiographs
of both hips and both stifles (knees) were performed to
ensure no musculoskeletal pathology was evident in any
dog prior to enrolment in the study.
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Orthopaedic assessments by a veterinary orthopaedic sur-
geon were performed on each dog at each time point
(preoperatively, and 8 weeks and 6 months after surgery).
The comfortable range of motion (CROM) of each hip was
measured using a goniometer. With the dog standing, one
limb of the goniometer was placed along the lateral axis of
the femur and the other arm placed along the lateral axis of
the pelvis from the centre of the iliac wing to the ischial
tuberosity with the hinge point centred over the greater
trochanter. The hip was then manually extended to the
highest angle the dog tolerated without showing resistance
or pain. The extension angle (degrees) noted on the goni-
ometer at this point was recorded. The hip was then
manually flexed to the most acute angle the dog tolerated
without showing resistance or pain. The flexion angle (de-
grees) noted on the goniometer at this point was recorded.
The flexion angle was subtracted from the extension angle
to determine the CROM for each hip. Clinical lameness
scores were determined for each dog at each time point
(preoperatively, and 8 weeks and 6 months after surgery)
based on a visual examination of gait by a veterinary or-
thopaedic surgeon using a 10-cm visual analogue scale and
a validated grading system [8]: “0” for no observable
lameness; “1” for intermittent, mild weight-bearing lame-
ness with little, if any, change in gait; “2” for moderate
weight-bearing lameness (obvious lameness with noticeable
gait change); “3” for severe weight-bearing lameness (“toe
touching” only); and “4” for nonweight bearing.Surgical model
With approval from the University of Missouri’s Animal Care
and Use Committee, the femoral heads of purpose-bred
adult (2e6 years old) mongrel dogs (n Z 10) were asepti-
cally harvested after humane euthanasia was performed for
reasons unrelated to this study. The femoral heads were
judged to be normal based on gross inspection prior to use.
The femoral heads were preserved at room temperature
(w25 C) using the Missouri Osteochondral Allograft Pres-
ervation System for 21 days prior to implantation [8].
On the day of the surgery, the recipient dogs were
premedicated with dexmedetomidine [5e10 mg/kg intra-
venous (IV)] and morphine (0.5 mg/kg IV). Anaesthesia was
then induced 30 minutes following premedication using
propofol (4e8 mg/kg IV). The right hindlimb of each dog
was prepared for aseptic surgery. After draping, a standard
craniolateral approach to the right hip (without osteotomy
or dislocation) was performed. Each dog was randomly
assigned to treatment of one hip with n Z 3 in each
treatment group. The graft-treatment options included: (1)
small osteochondral autograft (small auto): 6-mm-
diameter  6-mm-depth cylindrical autograft aseptically
obtained from the trochlear ridge of the ipsilateral knee (1
graft/knee) during the same surgical episode; (2) small OCA
(small allo): 6-mm-diameter  6-mm-depth cylindrical
allograft aseptically obtained from a size-matched canine
femoral head (1 graft/femoral head) of purpose-bred adult
(2e6 years old) mongrel dogs and prepared as described as
follows at the time of surgical implantation; and (3) largeOCA (large allo): 14-mm-diameter  6-mm-depth tapered
allograft procured from a size-matched canine femoral
head (one graft per femoral head) of purpose-bred adult
(2e6 years old) mongrel dogs and prepared as described as
follows at the time of surgical implantation.
With the hip adducted and externally rotated, grafts
were placed into the cranio(anterio)dorsal, primary load-
bearing aspect of the femoral head.
Small grafts were implanted into the same femoral head
(alternated between anterior and posterior) of three dogs
using commercially available press-fit cylindrical OCA
instrumentation (Arthrex, Inc., Naples, FL, USA) to create
each graft and each recipient socket (Figure 1).
Large grafts were implanted alone in the other three
dogs using press-fit tapered OCA instrumentation
(Comparative Orthopaedic Laboratory, University of Mis-
souri, Columbia, MO, USA) to create each graft and each
recipient socket (Figure 1).
The surgical wounds were closed routinely. Each dog
received implants in only one hip, and the contralateral
hips served as unoperated controls.
After the allografts were harvested and implanted,
chondrocyte viability in the remaining portions of the
femoral head was assessed as described as follows to
determine the chondrocyte viability at the time of
implantation.
The postoperative recovery was monitored, and anal-
gesics (morphine 0.5 mg/kg intramuscular followed by
tramadol 2e4 mg/kg postoperative) were administered to
the dogs for 3 days following surgery. The dogs were
allowed unrestricted activity in their individual kennels,
and were walked on a leash for 15 minutes 5 times/wk.
Postoperative assessments
Eight weeks and 6 months after surgery, an orthopaedic ex-
amination to assess the hip CROM and the clinical lameness
and function was performed on each dog as described pre-
viously. At each of these time points, the dogs were pre-
medicated and anaesthetised as described previously for
radiographic and arthroscopic assessments. Radiographic
assessments were performed by one veterinary radiologist.
The ventrodorsal and lateral views of the hips were evalu-
ated for graft incorporation and radiographic criteria for
osteoarthritis [23,24]. An arthroscopic assessment of the
operated hips was performed using standard portals and
technique [23]. The hips were assessed for appearance and
integrity of the grafts and the surrounding and apposing
articular cartilage, aswell as the degree of synovitis present.
Postmortem assessments
After humane euthanasia was performed under anaes-
thesia, the operated hip from each dog was carefully
dissected and disarticulated for tissue processing by a
veterinary pathologist, who was blinded to treatment
groups and clinical findings. Sections from each femoral
head were immediately prepared for the determination of
chondrocyte viability. The chondrocyte viability in con-
structs was assessed using two stains to detect live and
dead cells (Molecular Probes; Thermo Fisher Scientific,
Figure 1 Clinical photo of canine (A) small-autograft (top left) and small-allograft harvest (top right) and implantation, and (B)
large-allograft harvest and implantation.
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protocol, where live cells are stained green with calcein AM
and dead cells are stained with SYTOX Blue (Thermo Fisher
Scientific). The percent chondrocyte viability for each graft
was quantified using digital image analysis [8].
The remaining portion of each femoral head was placed
in 10% neutral buffered formalin fixative. After fixation,
tissues were decalcified using 10% EDTA in phosphate-
buffered saline until the end point of decalcification was
reached as indicated by the ammonium-oxalate test (i.e.,
absence of detectable calcium in the decalcifying fluid).
After decalcification, the tissues were dehydrated, paraffin
embedded, and cut on a microtome into 5-mm sections for
histologic examination. The specimens were deparaffi-
nised; rehydrated; and stained with haematoxylin and eosin
to determine the cell distribution and tissue morphology,
with toluidine blue to assess the proteoglycan distribution,
and with picrosirius red to determine the collagen integrity
[25]. The osteochondral sections were evaluated by two
veterinary pathologists who were blinded to the treatment
group and clinical findings, and were scored based on the
criteria described in the Osteoarthritis Research Society
International histologic assessment system for dogs [26].
Statistical analyses
All statistical analyses were performed using SigmaPlot
(Systat Software, Inc., San Jose, CA, USA). Comparisonsbetween the three treatment groups were performed using
one-way analysis of variance and the HolmeSida´k method
for multiple pairwise comparisons for continuous data, and
KruskaleWallis one-way analysis of variance on ranks and
Tukey test for multiple pairwise comparison procedures for
categorical data. Differences with p  0.05 were consid-
ered statistically significant.
Human patients
Based on data from the canine study, four human patients
underwent fresh (<28-day storage) osteochondral allog-
rafting using large (>30-mm diameter) size-matched
femoral-head grafts. Three patients had post-traumatic
avascular necrosis (acetabular fracture dislocation,
femoral neck fracture, and slipped capital femoral epiph-
ysis), and the last patient had an acute traumatic femoral-
head defect. The technique used for the human procedures
included a surgical hip dislocation as described by Ganz et al
[27]. The fresh grafts were obtained from certified tissue
banks and were stored using standard tissue-bank protocols
(4 C) for <28 days from harvest. They were harvested, and
the recipient site was prepared using the Arthrex graft sys-
tem. The grafts were implanted using manual pressure (no
mallet impaction) for a press-fit techniquewithout hardware
(Figure 2). Quality of life and functional assessments were
captured postoperatively. A similar type of large allograft
(>30 mm) was performed in the four patients.
Figure 2 Clinical photo of implantation of two osteochondral
allografts through a surgical dislocation in a 16-year-old male.
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All dogs had full CROM in both hips with no apparent hin-
dlimb lameness or dysfunction prior to surgery. All allo-
grafts had >80% chondrocyte viability at the time of
implantation based on liveedead staining of the remaining
portions of the femoral-head grafts. All grafts were suc-
cessfully implanted into each hip, and all dogs survived
surgery and recovered without complication. No evidence
for infection, graft rejection, or other untoward responses
was noted.
All grafts in each group showed radiographic evidence
for integration into the host bone by 8 weeks post-
operatively (Figure 3). However, only dogs in the large-allo
group were continued to the 6-month time point, as small-
auto and small-allo hips showed significant (p < 0.05)
lameness, dysfunction, and loss of CROM (Table 1), and
arthroscopic and radiographic evidence for loss of articular-Figure 3 Anteroposterior canine hip radiograph of (A) small autocartilage integrity with associated osteoarthritis at the 8-
week assessment point. Therefore, these dogs underwent
humane euthanasia under anaesthesia at this time point to
characterise further the pathology by assessing the chon-
drocyte viability and histology as intended.
Hips in the large-allo group showed no significant loss of
function or CROM when compared to the contralateral
control hips at 8 weeks and 6 months after surgery
(Table 1). The radiographic assessment of the large-allo
hips showed graft integration into the host bone at 8
weeks postoperatively with absence of any radiographic
evidence for osteoarthritis for all dogs throughout the 6-
month study period (Figure 3). The arthroscopic assess-
ment of the large-allo hips revealed maintenance of
integrity of all grafts with lack of articular-cartilage pa-
thology of grafts, surrounding femoral-head cartilage, or
apposing acetabular cartilage (Figure 4). Mild synovitis was
noted in each hip.
The percent chondrocyte viability was maintained at
levels documented to be associated with long-term graft
function for 6 months after implantation in large-allo grafts
[8]. At 8 weeks after implantation, the percent chon-
drocyte viability in small-allo and small-auto grafts was
significantly (p < 0.05) lower than in the large-allo grafts,
and well below the levels associated with long-term success
(Table 2, Figures 4 and 5).
Based on the histologic assessments, the small-allo and
small-auto grafts had significantly (p < 0.05) more severe
(higher score) pathology at 8 weeks after implantation
when compared to the large-allo grafts at 6 months after
implantation (Table 2). The small-auto grafts were associ-
ated with the most severe pathology. In the small grafts,
histopathologic findings consisted of articular surface
fibrillation and fissuring, loss of proteoglycan staining,- and allograft at 8 weeks, and (B) large allograft at 6 months.
Table 1 Functional outcome measures.
Group 2 mo 6 mo
Lameness Function CROM Lameness Function CROM
Normal 0  0 10  0 141  3 0  0 10  0 142  4
Small 2.3  0.6* 7.5  0.5* 108  3*
Large 0.7  0.6 9  0.2 135  4 0.3  0.6 9.8  0.4 139  5
* Indicates statistically significant (p < 0.05, rank-sum test) difference from others in the column.
CROM Z comfortable range of motion.
Table 2 Chondrocyte viability and histologic scores.






Small auto NA 19  13 a 48  10 c
Small allo 92  9 22  23 a 29  3 d
Large allo 90  11 84  14 b 14  4 e
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drocyte necrosis and/or apoptosis at 8 weeks after im-
plantation (Figure 4). Histologically, the large-allo grafts
showed maintenance of hyaline cartilage structure and
integrity with only focal, minor decreased proteoglycan
staining and chondrocyte necrosis and/or apoptosis at the
periphery of grafts (Figure 5).Different letters indicate statistically significant (p < 0.05,
rank-sum test) difference from others in the column.
% CV Z % chondrocyte viability; NA Z not applicable.Human patients
Using large allografts, three out of the four patients
required two grafts at the time of implantation due to the
defect size. At the time of this abstract, patient follow up
ranged from 4 months to 18 months. All patients are full
weight bearing without an assistive device, and show no
evidence of graft failure or progressive arthrosis. No pa-
tient was requiring narcotic pain medication or any reg-
ular anti-inflammatories. One patient was occasionally
using tramadol, but rated her pain 0 out of 10 at her 18-Figure 4 (A) Chondrocyte viability for small autograft showing
histological evaluation showing mostly fibrous tissue at the graft s
chondrocytes dead on (C) viability staining, but some peripheral g
evaluation.month visit, but could reach up to 4 out of 10 with
activities.
Discussion
The results of this translational canine model study suggest
that OCAs created and implanted using tapered OCAthe majority of graft chondrocytes dead (red stain), and (B)
ite. The small allograft evaluation showed a similar amount of
raft incorporation and remaining cartilage on (D) histological
Figure 5 Evaluation of the large allograft: (A) chondrocyte viability showing the majority of chondrocytes to be viable (green)
except for at the graft seam; (B) histological evaluation showing good graft incorporation and chondrocytes; and (C) arthroscopic
evaluation at 6 months showing good graft articular surface without irregularity except at graft seam.
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femoral head are superior to smaller cylindrical allografts
and autografts. The large allografts were significantly bet-
ter for all clinical and histological evaluations. Although all
grafts showed evidence for incorporation into the host bone
radiographically, the large allografts retained chondrocyte
viability and function at 6 months, whereas the small grafts
required early sacrifice at 8 weeks due to poor clinical
function.
Mosaicplasty, the use of small autologous osteochondral
plugs, has been used more commonly in the knee, but has
been described in the hip as well [28,29]. Typically, this
technique is used for cartilage lesions <2 cm2 for the
femoral head [29] and 2.5 cm2 for the femoral condyle [28].
Although the technique is beneficial in smaller lesions, use
for larger lesions is cautioned when multiple grafts are
required due to donor-site morbidity, peripheral graft
chondrocyte death during graft harvest [30], chondrocyte
death during impaction of the graft, graft-height mismatch
[31], and the long-term effect of fibrocartilage fill between
grafts [28]. However, using large allografts leads to fewer
grafts harvested (fewer chondrocytes die), manual pressure
used for press-fit technique (fewer chondrocytes die), and
fewer articular surface irregularitiesdfewer seams and
opportunities for graft-height mismatch.
Previous clinical reports are few, but osteochondral
grafts have been clinically successful in the femoral head.
Indications for this procedure usually have few available
alternatives. Avascular necrosis without segmental collapse
and traumatic defects are the most common indications.
Unfortunately, these problems usually occur in youngpatients who are not good arthroplasty candidates, and
most patients would like to avoid arthrodesis. Although a
proximal femoral osteotomy can be used to offload the
affected area, it is technically challenging and is not a
viable option if the femoral-head defect is too large
[32,33]. Unfortunately, arthrosis is inevitable.
If osteochondral allografting is being considered, early
detection is important because the patient should not have
radiographic signs of arthrosis. The contraindications for this
procedure include inflammatory arthritis, avascular necrosis
with segmental collapse, and evidence of arthrosis [7].
Previous case reports have shown the technique can be
successful. Evans and Providence [4] reported the success
of the technique for a patient with osteochondritis dis-
secans after trauma with short-term follow up.
To date, three case series have been published. The first
clinical series with relatively long-term follow up was re-
ported in 1985 [7]. Meyers [7] reported his results of 25 hips
in 21 patients using fresh OCAs. The procedure was consid-
ered a success if the patient had minimal pain, did not
require narcotic pain management, and was ambulating
without an assistive device. Follow up ranged from 9 months
to 63 months. Fifty percent (5/10) of the patients with
avascular necrosis and segmental collapse, or those who
were taking chronic steroids failed. Most failures occurred
within the 1st year, and all failures went on to total hip
arthroplasty. Eighty percent (12/15) of the patients without
a steroid-related aetiology were considered successful.
The procedure does appear to improve the Harris hip
scores [5,6]. Kosashvili et al [6] reported on eight patients
with up to 24-months follow up and showed a 26.2 average
Femoral-head OCA transplant preclinical model 55improvement in Harris hip scores. Six out of eight (75%)
patients had “good mobility” and had functional grafts at
42 months. Two patients (25%) were considered to have
graft failures. Likewise, Khanna et al [5] reported the first
prospective case series and showed significant improve-
ment in Harris hip scores with average follow up of 41.6
months. Postoperative magnetic -resonance-imaging graft
evaluation was performed in 10 of 17 patients. Thirteen of
17 (76.5%) patients had fair or good outcomes. The post-
operative magnetic resonance imaging finding appeared to
have no correlation with functional results. They also rec-
ommended not performing the procedure on patients that
have a steroid-related aetiology.
Large OCA procedures for the femoral head may require
larger prospective series with longer follow up to prove their
effectiveness. The previous series do not report the average
size of the defect grafted. Defect size may play a role in
patient selection and eventual success of the procedure.Study limitations
Although statistically significant differences were realised
for all outcome measures, there are limitations to this
study. With only three dogs in each group and small auto-
grafts and small allografts placed in the same hips, it is not
possible to clearly delineate which variables were respon-
sible for the significant differences noted. The failure of
the small grafts may have been influenced by their relative
size and associated biomechanics, the instrumentation
system used, and/or their relative positioning and prox-
imity in the femoral head. However, the study design did
allow for narrowing down the causes of significant differ-
ences to graft size and/or the instrumentation system used,
in that preservation was the same for all allografts, an
autograft control was used for small grafts, small autografts
and allografts were alternated in location, and the use of
multiple small grafts together mimics the clinical standard
of care. Therefore, the significantly better outcomes
associated with large allografts are likely due to the larger
size more optimally restoring the articular surface contour
of the femoral head with improved biomechanics and/or
providing more donor chondrocytes to preserve, which
were better preserved with the use of the tapered instru-
mentation system that does not require tamping.
Lastly, the data from human patients are based on a very
small single-centre series with short-term follow up, and
even the published clinical series do not have follow up
greater than w5 years [5e7]. Therefore, further trans-
lational and clinical studies are required before definitive
conclusions regarding the safety, efficacy, and optimal
technique can be made.
These data provide initial translational and clinical evi-
dence for large OCAs as a potential option for functional
resurfacing of full-thickness cartilage defects of the
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